Spinal muscular atrophy (SMA) is a rare neurodegenerative disease caused by the absence of survival motor neuron (SMN) protein. SMN loss results in impairments of the cytoskeleton, including microtubules and regulatory proteins. However, the contribution of microtubule-associated proteins (MAPs) to microtubule dysregulations in SMA is not fully understood. In this study, we investigated neuronal MAPs responsible for the microtubule stability and growth, including MAP1A, MAP2, MAP6, MAP7, EB1, and EB3 using an in vitro model of SMA. Decreased MAP2 and EB3 levels were found in SMN-deficient motor neuron-like cells, and EB3 protein level was also relevant to MAP1B. SMN loss leads to an increase in EB3 comet numbers at proximal neurites, indicating increased microtubule growth. Our findings suggest that SMN deficiency simultaneously causes dysregulations of several MAPs, contributing to the perturbations of microtubule dynamics in SMA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.mcn.2022.103725 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy.
Cell Rep
January 2025
Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA; Department of Neurology, Columbia University, New York, NY 10032, USA; Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA. Electronic address:
Article Synopsis
- Understanding posture is crucial for how mammals move, and dysregulation of certain brain chemicals, specifically dopamine and noradrenaline, can lead to motor problems in diseases like spinal muscular atrophy (SMA).
- Research using a mouse model of SMA revealed that the loss of synapses in the spinal neurons, caused by non-cell autonomous mechanisms, contributes to motor dysfunction and postural issues.
- Restoring a specific protein (survival motor neuron) in either catecholaminergic or serotonergic neurons can improve movement, but significant postural issues only improve with restoration in both neuron types or treatment with l-dopa, highlighting new potential treatment strategies.
Spinal muscular atrophy is also a disorder of spermatogenesis.
Orphanet J Rare Dis
December 2024
Centre de Référence Des Maladies Neuromusculaires AOC, CHU de Nantes, Filnemus, Euro-NMD, Hôtel Dieu, Nantes, France.
Background: Spinal muscular atrophy (SMA) patients benefit from pre-mRNA splicing modifiers targeting the SMN2 gene, which aims to increase functional SMN production. The animal toxicity affecting spermatogenesis associated with one such treatment raised questions about male SMA patients' spermatogenesis.
Methods: This descriptive, cross-sectional study was conducted from June 2022 to July 2023.
[Natural history of spinal muscular atrophy type I].
Zh Nevrol Psikhiatr Im S S Korsakova
December 2024
JSC BIOCAD, St. Petersburg, Russia.
Spinal muscular atrophy (SMA) is a group of genetically heterogeneous neuromuscular diseases characterized by the progressive loss of motor neurons in the anterior horns of the spinal cord. The prevalence of SMA is approximately 1 in 10.000 live births.
View Article and Find Full Text PDFSMN Deficiency Induces an Early Non-Atrophic Myopathy with Alterations in the Contractile and Excitatory Coupling Machinery of Skeletal Myofibers in the SMN∆7 Mouse Model of Spinal Muscular Atrophy.
Int J Mol Sci
November 2024
Department of Basic Medical Sciences, Institute of Biomedical Technologies (ITB), Universidad de La Laguna, 38200 San Cristobal de la Laguna, Spain.
Article Synopsis
- Spinal muscular atrophy (SMA) is caused by a lack of survival motor neuron (SMN) protein, leading to the degeneration of lower motor neurons and muscle atrophy.
- Early research in SMNΔ7 mice showed signs of motor dysfunction and myofiber changes before muscle denervation occurred, highlighting that SMN deficiency has direct effects on muscle cells.
- The study revealed ultrastructural abnormalities in muscle fibers, including disruptions in the myofibrillar structure and altered mitochondrial dynamics, suggesting that muscle changes occur independently of motor neuron loss in SMA.
MicroRNAs as Biomarkers in Spinal Muscular Atrophy.
Biomedicines
October 2024
Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Spinal muscular atrophy (SMA) is a severe neurodegenerative disease caused by the loss of the survival motor neuron (SMN) protein, leading to degeneration of anterior motor neurons and resulting in progressive muscle weakness and atrophy. Given that SMA has a single, well-defined genetic cause, gene-targeted therapies have been developed, aiming to increase SMN production in SMA patients. The SMN protein is likely involved in the synthesis of microRNAs (miRNAs), and dysregulated miRNA expression is increasingly associated with the pathophysiology of SMA.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!